Recently, Journal of Clinical Medicine (JCM, ISSN: 2077-0383) held the Editor-in-Chief and Section Editors-in-Chief Annual Meeting on 17 February 2025, 8:30–10:00 CET. This significant event was hosted by the Editor-in-Chief, Prof. Dr. Kent Doi, and fifteen Section Editors-in-Chief were in attendance, each bringing their unique expertise and insights. We are grateful for the support of all attendees. This meeting presented an opportunity for us to come together to review the journal’s past developments and look forward to a better year.

We reviewed and discussed the following topics with the attendees:

• An overview of the journal’s performance in 2024;
• The current Section status, a new Section established, and hot topic data;
• Marketing activities, virtual conferences, society cooperation, journal awards, and social media promotion.

The following information was covered in the discussion:

• Currently, the publication and citation data of the journal are satisfactory. In 2025, with the aim of enhancing the journal’s impact factor, the Editorial Board Members put forward suggestions regarding, for example, the types of submissions, the peer-review process, and setting goals for different Sections;
• Marketing promotion activities were discussed. Members showed their interest in the upcoming International Online Conference on Clinical Medicine (IOCCM) 2025. The registration for attendees is completely free of charge. We are calling for speakers and topic suggestions from attendees;
• The Editorial Board Members gave detailed suggestions on how to strengthen cooperation with societies to increase the exposure of the journal and promote wider scholarly communication.

Attendee list (Sections are ordered alphabetically, in no particular order):

• Prof. Dr. Kent Doi (Editor-in-Chief), Department of Acute Care Medicine, University of Tokyo, Tokyo, Japan;
• Prof. Dr. Luis Garcia-Marcos (“Clinical Pediatrics” Section Editor-in-Chief), Respiratory and Allergy Units, Arrixaca Children’s University Hospital, University of Murcia, Murcia, Spain;
• Dr. Stefanos Bonovas (“Clinical Research Methods” Section Editor-in-Chief), ¹ Department of Biomedical Sciences, Humanitas University, Milan, Italy; ² IRCCS Humanitas Research Hospital, Milan, Italy;
• Prof. Dr. Gregory Y. H. Lip (“Cardiology” Section Editor-in-Chief), ¹ Price-Evans Professor of Cardiovascular Medicine, University of Liverpool, Liverpool, UK; ² Distinguished Professor, Aalborg University, Aalborg, Denmark;
• Prof. Dr. Mario Plebani (“Clinical Laboratory Medicine” Section Editor-in-Chief), Department of Laboratory Medicine, University-Hospital of Padova, Padova, Italy;
• Prof. Dr. Francisco Guillen-Grima (“Epidemiology & Public Health” Section Editor-in-Chief), ¹ Department of Preventive Medicine, Clinica Universidad de Navarra, University of Navarra, Pamplona, Spain; ² Navarra Medical Research Institute (IdiSNA), Pamplona, Spain; ³ Center for Biomedical Research Network Epidemiology and Public Health, Madrid, Spain; ⁴ Department of Health Sciences, Public University of Navarra, Pamplona, Spain;
• Prof. Dr. Michael Christ (“Emergency Medicine” Section Editor-in-Chief), Emergency Department, Luzerner Kantonsspital, Luzern, Switzerland;
• Prof. Dr. Hidekazu Suzuki (“Gastroenterology & Hepatopancreatobiliary Medicine” Section Editor-in-Chief), Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai University School of Medicine, Kanagawa, Japan;
• Dr. Carlo Finelli (“Hematology” Section Editor-in-Chief), ¹ Italian MDS Foundation (FISIM - ETS), Bologna, Italy; ² IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy;
• Prof. Dr. Karim Bendjelid (“Intensive Care” Section Editor-in-Chief), CardioVascular Unit, Intensive Care Division, Geneva University Hospitals, Switzerland;
• Prof. Dr. Robert Flisiak (“Infectous Diseases” Section Editor-in-Chief), Department of Infectious Diseases and Hepatology, Medical University of Białystok, Białystok, Poland;
• Prof. Dr. Icro Maremmani (“Mental Health” Section Editor-in-Chief), Vincent P. Dole Dual Disorder Unit, Institute of Behavioural Sciences, Pisa, Italy;
• Prof. Dr. Alberto Signore (“Nucelar Medicine & Radiology” Section Editor-in-Chief), Department of Surgical-Medical Sciences and Translational Medicine, University of Rome “Sapienza”, Rome, Italy;
• Prof. Dr. Eyal Sheiner (“Obstetrics & Gynecology” Section Editor-in-Chief), Department of Obstetrics and Gynecology, Soroka University Medical Center, Beersheba, Israel;
• Dr. Nicholas David Clement (“Orthopedics” Section Editor-in-Chief), Edinburgh Orthopaedics, Royal Infirmary of Edinburgh, Edinburgh, UK;
• Dr. Sukhwinder Singh Sohal (“Pulmonology” Section Editor-in-Chief), Respiratory Translational Research Group, Department of Laboratory Medicine, College of Health and Medicine, University of Tasmania, Launceston, Australia.

The latest official CiteScore (2023 Scopus data) for the Journal of Clinical Medicine is 5.7, ranking 80/636 (Q1) in the “General Medicine” category. The current Impact Factor of JCM is 3.0 (2023), ranking 59/329 (Q1) in the “Medicine, General, and Internal” category. To access more journal statistics, please click here.